PURETECH ANNOUNCES PRESENTATION OF PHASE 1B RESULTS FOR LYT-200 IN RELAPSED/REFRACTORY (R/R) HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) AND ACUTE MYELOID LEUKEMIA (AML) AT ESMO 2026

Reuters · 4d ago

Please log in to view news